Aigen Investment Management, LP Xeris Biopharma Holdings, Inc. Transaction History
Aigen Investment Management, LP
- $597 Million
- Q3 2025
A detailed history of Aigen Investment Management, LP transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Aigen Investment Management, LP holds 19,129 shares of XERS stock, worth $138,685. This represents 0.03% of its overall portfolio holdings.
Number of Shares
19,129
Previous 16,769
14.07%
Holding current value
$138,685
Previous $92,000
67.39%
% of portfolio
0.03%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding XERS
# of Institutions
237Shares Held
94.4MCall Options Held
251KPut Options Held
61.8K-
Black Rock Inc. New York, NY10.3MShares$74.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.83MShares$71.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.84MShares$42.3 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA4.14MShares$30 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$27.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $986M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...